Mark Torres, MD
Ophthalmology · Sandpoint, IDNPI 1255399457
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Alcon at 47.0% of the total. Reporting peaked in 2023 at $651 and has fallen 62.5% since, to $244 in 2025.
Across 48 payments — averaging $53.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Carl Zeiss Meditec USA, Inc.$659
- Carl Zeiss Meditec, Inc.$254
- Rayner Intraocular Lenses Limited$162
- Johnson & Johnson Surgical Vision, Inc.$109
- Beaver-visitec International, Inc.$73
- plus $115 from 3 others
What the payments were for
- Food & beverage$2,54798%
- Gifts$392%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 25 | $1,216 |
| Carl Zeiss Meditec USA, Inc. | 10 | $659 |
| Carl Zeiss Meditec, Inc. | 4 | $254 |
| Rayner Intraocular Lenses Limited | 3 | $162 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $109 |
| Beaver-visitec International, Inc. | 1 | $73 |
| Glaukos Corporation | 1 | $40 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Sight Sciences, Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,586 in reported general payments places this provider in the 75th percentile of 60 ophthalmology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 112 | $790 |
| Timolol Maleate | 26 | $508 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 26 | $498 |
| Prednisolone Acetate | 17 | $467 |
| Dorzolamide Hcl | 14 | $211 |
| Doxycycline Hyclate | 12 | $163 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Sandpoint
- Adam ReynoldsBoise$47K
- Ryan BarrettBoise$7K
- Landon GrangeBoise$5K
- Jacob MongBoise$5K
- Ali Torab ParhizBoise$5K
- Alison GranierCoeur D Alene$4K
- David DanceCoeur D Alene$4K
- Gregory KentBoise$4K
- Michael MerkleyMeridian$3K
- Mark HollingsheadBoise$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.